Sonsoles Velázquez - Concepedia

Author

Sonsoles Velázquez

Also Known As

S Velazquez, S Velázquez, S Vélazquez, S. VELAZQUEZ, S. Velazquez, S. Velázquez, Sonsoles Velazquez, Sonsoles Velázquez, Sonsoles Velázquez, Sonsolez Velázquez

132

Publications

Citations

H-Index

Concepts

All Affiliations

Instituto de Química Médica Rega Institute for Medical Research KU Leuven Universidad de Alcalá Consejo Superior de Investigaciones Científicas

About

Sonsoles Velázquez is an author at Instituto de Química Médica specializing in medicine, natural sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	935
2	Natural Sciences	15	20	904
3	Biochemistry	13	16	650
4	Biomolecular Engineering	5	5	289
5	Engineering	2	2	34

Sonsoles Velázquez

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) Analogs: Synthesis and Anti-HIV-1 Activity Rosa Álvarez, Sonsoles Velázquez, Ana San‐Félix, Journal of Medicinal Chemistry	1994	746
Regiospecific Synthesis and Anti-Human Immunodeficiency Virus Activity of Novel 5-Substituted <i>N</i>-Alkylcarbamoyl and <i>N,N</i>-Dialkyl Carbamoyl 1,2,3-Triazole-TSAO Analogues Sonsoles Velázquez, Rosa Álvarez, Carlos A. Perez, Antiviral chemistry & chemotherapy Bioorganic ChemistryOrganic ChemistryAntiviral DrugPharmaceutical ChemistryRegiospecific Synthesis	1998	223
Potent and Selective Inhibition of Varicella-Zoster Virus (VZV) by Nucleoside Analogues with an Unusual Bicyclic Base Christopher McGuigan, Christopher J. Yarnold, Garry Jones, Journal of Medicinal Chemistry Lead CompoundsNew CategoryMedicinal ChemistryMedicineVaricella-zoster Virus	1999	187
Characterization of the Activation Pathway of Phosphoramidate Triester Prodrugs of Stavudine and Zidovudine Didier Saboulard, Lieve Naesens, Dominique Cahard, Molecular Pharmacology	1999	111
Resistance of HIV-1 reverse transcriptase against [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5“-(4”-amino-1“,2”- oxathiole-2“,2”-dioxide)] (TSAO) derivatives is determined by the mutation Glu138–>Lys on the p51 subunit. Heidi Jonckheere, Jean‐Marc Taymans, Jan Balzarini, Journal of Biological Chemistry	1994	90
Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus Christopher McGuigan, Ranjith Pathirana, Marco Migliore, Journal of Antimicrobial Chemotherapy	2007	73
Antivascular and antitumor properties of the tubulin-binding chalcone TUB091 María-Dolores Canela, Sam Noppen, Oskía Bueno, Oncotarget Prodrug ApproachPharmaceutical ScienceCytoskeletonNew SeriesChemical Biology	2016	69
Phosphoramidate derivatives of d4T as inhibitors of HIV: The effect of amino acid variation Christopher McGuigan, Hing-Wo Tsang, Dominique Cahard, Antiviral Research Medicinal ChemistryBiochemistryMedicineNatural SciencesAntiviral Drug Development	1997	65
[2',5'-Bis-O-(tert-butyldimethylsilyl)]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) (TSAO) derivatives of purine and pyrimidinenucleosides as potent and selective inhibitors of human immunodeficiency virus type 1 Jan Balzarini, María‐Jesús Pérez‐Pérez, Ana San‐Félix, Antimicrobial Agents and Chemotherapy ImmunologySelective InhibitorsSarcoma VirusPharmacotherapyAntiviral Drug	1992	56
Identification of a Putative Binding Site for [2‘,5‘-Bis-<i>O</i>-(<i>tert</i>-butyldimethylsilyl)-β-<scp>d</scp>-ribofuranosyl]-3‘-spiro-5‘ ‘-(4‘ ‘-amino-1‘ ‘,2‘ ‘-oxathiole-2‘ ‘,2‘ ‘-dioxide)thymine (TSAO) Derivatives at the p51−p66 Interface of HIV-1 Reverse Transcriptase Fátima Rodrı́guez-Barrios, Carlos A. Perez, Esther Lobatón, Journal of Medicinal Chemistry	2001	56

Page 1